BRUKER CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that BRUKER CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $553.60M | Mar 1, 2019 |
| FY2018 | Sep 30, 2018 | $466.60M | Mar 1, 2019 |
| FY2018 | Jun 30, 2018 | $443.70M | Mar 1, 2019 |
| FY2018 | Mar 31, 2018 | $431.70M | Mar 1, 2019 |
| FY2018 | Dec 31, 2017 | $530.50M | Mar 1, 2019 |
| FY2018 | Sep 30, 2017 | $435.60M | Mar 1, 2019 |
| FY2018 | Jun 30, 2017 | $414.90M | Mar 1, 2019 |
| FY2018 | Mar 31, 2017 | $384.90M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $470.30M | Mar 16, 2018 |
| FY2017 | Sep 30, 2016 | $393.90M | Mar 16, 2018 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.44B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $3.37B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $2.96B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $2.53B | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $2.42B | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $1.99B | Mar 1, 2023 |
| FY2019 | Dec 31, 2019 | $599.90M | Mar 27, 2020 |
| FY2019 | Sep 30, 2019 | $521.10M | Mar 27, 2020 |
| FY2019 | Jun 30, 2019 | $490.20M | Mar 27, 2020 |
| FY2019 | Mar 31, 2019 | $461.40M | Mar 27, 2020 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.58B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.65B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $1.51B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $1.31B | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $1.21B | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $939.80M | Mar 1, 2023 |
| FY2019 | Dec 31, 2019 | $296.30M | Mar 27, 2020 |
| FY2019 | Sep 30, 2019 | $253.90M | Mar 27, 2020 |
| FY2019 | Jun 30, 2019 | $230.40M | Mar 27, 2020 |
| FY2019 | Mar 31, 2019 | $214.70M | Mar 27, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($8.60M) | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $113.10M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $427.20M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $296.60M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $277.10M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $157.80M | Mar 1, 2023 |
| FY2019 | Dec 31, 2019 | $68.60M | Mar 27, 2020 |
| FY2019 | Sep 30, 2019 | $61.30M | Mar 27, 2020 |
| FY2019 | Jun 30, 2019 | $36.50M | Mar 27, 2020 |
| FY2019 | Mar 31, 2019 | $30.80M | Mar 27, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $68.20M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $253.10M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $436.90M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $432.70M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $413.30M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $248.30M | Mar 1, 2023 |
| FY2019 | Dec 31, 2019 | $117.70M | Mar 27, 2020 |
| FY2019 | Sep 30, 2019 | $87.80M | Mar 27, 2020 |
| FY2019 | Jun 30, 2019 | $53.50M | Mar 27, 2020 |
| FY2019 | Mar 31, 2019 | $41.90M | Mar 27, 2020 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $395.20M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $376.50M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $294.80M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $235.90M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $220.80M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $198.00M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $187.70M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $173.40M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $161.60M | Mar 27, 2020 |
| FY2018 | Dec 31, 2016 | $147.90M | Mar 1, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $946.50M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $893.80M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $729.40M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $607.40M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $561.20M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $468.60M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $500.20M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $444.70M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $415.20M | Mar 27, 2020 |
| FY2018 | Dec 31, 2016 | $389.80M | Mar 1, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $134.10M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $251.30M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $350.10M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $274.40M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $282.40M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $332.20M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $213.40M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $239.70M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $154.40M | Mar 27, 2020 |
| FY2018 | Dec 31, 2016 | $130.80M | Mar 1, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $90.80M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $115.30M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $106.90M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $129.20M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $92.00M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $97.20M | Mar 1, 2023 |
| FY2022 | Feb 26, 2020 | $12.30M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $73.00M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $49.20M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $43.70M | Mar 27, 2020 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.24B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $5.81B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $4.25B | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $3.61B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $3.65B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $3.05B | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $2.77B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $2.13B | Mar 27, 2020 |
| FY2018 | Dec 31, 2017 | $1.95B | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $1.81B | Mar 16, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.73B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $3.99B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $2.84B | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $2.48B | Feb 29, 2024 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.46B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.78B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $1.38B | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $1.11B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $1.07B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $961.20M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $906.80M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $896.60M | Mar 27, 2020 |
| FY2018 | Dec 31, 2017 | $725.40M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $686.40M | Mar 16, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.55B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.51B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $582.60M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $457.60M | Mar 3, 2025 |
| FY2024 | Dec 31, 2021 | $339.50M | Mar 3, 2025 |
| FY2023 | Dec 31, 2020 | $320.40M | Feb 29, 2024 |
| FY2022 | Dec 31, 2019 | $293.00M | Mar 1, 2023 |
| FY2021 | Dec 31, 2018 | $275.70M | Feb 28, 2022 |
| FY2020 | Dec 31, 2017 | $169.80M | Mar 1, 2021 |
| FY2019 | Dec 31, 2016 | $130.60M | Mar 27, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.36B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $2.41B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $2.32B | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $1.93B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $1.66B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $1.41B | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $1.27B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $1.10B | Mar 27, 2020 |
| FY2018 | Dec 31, 2017 | $942.00M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $885.20M | Mar 16, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $298.80M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $183.40M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $488.30M | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $645.50M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $1.07B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $681.80M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $678.30M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $322.40M | Mar 27, 2020 |
| FY2018 | Dec 31, 2017 | $325.00M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $342.40M | Mar 16, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.87B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $2.09B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $1.28B | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $1.22B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $1.33B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $844.50M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $813.30M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $341.10M | Mar 27, 2020 |
| FY2014 | Dec 31, 2014 | $355.00M | Feb 27, 2015 |
| FY2014 | Dec 31, 2013 | $355.00M | Feb 27, 2015 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Mar 1, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Mar 27, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Mar 27, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Mar 27, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Mar 27, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Mar 1, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Mar 27, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Mar 27, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Mar 27, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Mar 27, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 152.14M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 151.68M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | 145.16M | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | 147.02M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | 150.75M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | 151.99M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | 154.16M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | 156.61M | Mar 27, 2020 |
| FY2018 | Dec 31, 2017 | 155.87M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | 159.85M | Mar 16, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $22.80M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $30.20M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $29.40M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $29.80M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $24.20M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $24.60M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $25.00M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $25.10M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $25.40M | Mar 27, 2020 |
| FY2017 | Dec 22, 2017 | $6.30M | Mar 16, 2018 |